Temporary hold for guidance from the FDA that will adequately explain the new protocol of development.
It is nature at work, customary if you will, for any business to adjust and refine their endeavor for advancement. Which is why experience is so important. Many pitfalls can be avoided and planned for to limit or guard against. The extra burden of pre-development pharmas is getting the gatekeeper FDA satisfied. A politicized gatekeeper is a formidable foe, or formidable ally, It's kind of like paying the mafia for "protection", hence pay to play that is all too common business practice in this modern bastardized capitalistic system that has evolved. This infectious game needs to take a hard look at itself to get back on a proper course or risk bringing the whole thing to a painful grand finale. Leronlimab may have a much bigger role for healing should such a calamity abruptly appear.
$CYDY$
Bullish
News 
Market Data 
Discover 
